Cantley Lewis Clayton Jr. 4
4 · AGIOS PHARMACEUTICALS INC · Filed Dec 8, 2017
Insider Transaction Report
Form 4
Cantley Lewis Clayton Jr.
Director10% Owner
Transactions
- Sale
Common stock
2017-12-06$58.95/sh−254$14,973→ 80,638 total(indirect: See footnote) - Sale
Common stock
2017-12-06$60.01/sh−204$12,242→ 80,394 total - Sale
Common stock
2017-12-07$60.45/sh−631$38,144→ 79,515 total(indirect: See footnote) - Sale
Common stock
2017-12-06$58.95/sh−253$14,914→ 80,598 total - Sale
Common stock
2017-12-06$60.01/sh−204$12,242→ 80,434 total(indirect: See footnote) - Sale
Common stock
2017-12-07$59.68/sh−288$17,188→ 80,146 total(indirect: See footnote) - Sale
Common stock
2017-12-06$57.90/sh−542$31,382→ 80,892 total(indirect: See footnote) - Sale
Common stock
2017-12-06$57.90/sh−543$31,440→ 80,851 total - Sale
Common stock
2017-12-07$59.68/sh−288$17,188→ 80,106 total - Sale
Common stock
2017-12-07$60.45/sh−631$38,144→ 79,475 total
Holdings
- 20,803(indirect: See footnote)
Common stock
- 20,803(indirect: See footnote)
Common stock
Footnotes (9)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $57.48 to $58.30. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F3]Shares held by Vicki Lee Sato, who is the reporting person's spouse.
- [F4]The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $58.58 to $59.21. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F5]The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $59.62 to $60.55. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F6]The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $58.99 to $59.95. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F7]The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $60.00 to $60.79. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F8]Shares held by grantor retained annuity trusts for the benefit of the reporting person and his two children, of which the reporting person is trustee and sole annuitant.
- [F9]Shares held by grantor retained annuity trusts for the benefit of the reporting person's spouse and their two children, of which the reporting person's spouse is trustee and sole annuitant.